Hospital
Kaiser Foundation Hospitals
Kaiser Foundation Hospitals was paid $8.70M by Medicaid between Jan 2018 and Dec 2024, across 167 billing codes. Its largest line is 99284, emergency room visit (serious) — 24% of everything it billed.
33Billing provider infoKAISER FOUNDATION HOSPITALS
WALNUT CREEK, CA 94596
WALNUT CREEK, CA 94596
33aNPI1639244262assigned 11/21/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.70M
24GClaims420,704
24DCodes billed167
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#195 of 410
Median peer was paid$6.90M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,394 | $59K | |
| 2019 | 36,518 | $127K | |
| 2020 | 32,871 | $453K | |
| 2021 | 59,575 | $751K | |
| 2022 | 77,675 | $975K | |
| 2023 | 90,273 | $1.07M | |
| 2024incomplete | 109,398 | $5.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 8,153 | 7,646 | $2.05M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 13% | 8,664 | 8,413 | $1.10M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 5,879 | 5,690 | $1.09M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 2,511 | 2,357 | $938K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.3% | 2,666 | 2,613 | $459K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4.9% | 7,900 | 7,576 | $428K |
| G0378 | Hospital observation service, per hour | 4.6% | 2,065 | 1,443 | $403K |
| 0450 | Emergency room services | 2.2% | 5,460 | 4,521 | $192K |
| 71046 | Radiologic examination, chest; 2 views | 2.0% | 5,192 | 5,079 | $174K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.8% | 3,353 | 3,222 | $159K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.3% | 3,428 | 3,330 | $113K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 4,472 | 4,242 | $113K |
155 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.0% | 867 | $88K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,204 | $63K |
| 73630 | <1% | 2,129 | $55K | |
| 73610 | <1% | 1,653 | $53K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,677 | $50K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,682 | $43K |
| 0270 | <1% | 3,170 | $43K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 198 | $42K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 566 | $42K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 383 | $35K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 21,688 | $33K |
| 73030 | <1% | 998 | $31K | |
| 73130 | <1% | 1,061 | $30K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,067 | $29K |
| 74018 | <1% | 790 | $29K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 309 | $28K |
| 73564 | <1% | 474 | $28K | |
| 73110 | <1% | 803 | $28K | |
| 73560 | <1% | 783 | $28K | |
| 80051 | <1% | 14,481 | $26K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,527 | $26K |
| 36415 | Collection of venous blood by venipuncture | <1% | 21,938 | $24K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,211 | $24K |
| 72100 | <1% | 525 | $23K | |
| 73140 | <1% | 492 | $22K | |
| 86900 | <1% | 1,181 | $21K | |
| 99199 | Unlisted special service, procedure or report | <1% | 363 | $21K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,299 | $20K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 2,604 | $16K |
| 82565 | <1% | 16,280 | $15K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,570 | $14K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 30 | $14K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 57 | $14K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 704 | $14K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 93 | $14K |
| 73502 | <1% | 296 | $13K | |
| J3490 | Unclassified drugs | <1% | 4,469 | $13K |
| 83880 | <1% | 2,367 | $12K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 151 | $12K |
| 83690 | <1% | 8,407 | $11K | |
| 84460 | <1% | 10,646 | $11K | |
| 84484 | <1% | 5,352 | $11K | |
| 82247 | <1% | 10,947 | $10K | |
| 82947 | <1% | 14,551 | $10K | |
| 84520 | <1% | 14,522 | $10K | |
| 84450 | <1% | 9,980 | $10K | |
| 70491 | <1% | 43 | $10K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,579 | $10K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,367 | $9K |
| 73080 | <1% | 122 | $9K | |
| 86850 | <1% | 1,032 | $9K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,583 | $8K |
| 84075 | <1% | 9,165 | $8K | |
| 81001 | <1% | 10,825 | $7K | |
| 76830 | Ultrasound, transvaginal | <1% | 135 | $7K |
| 73590 | <1% | 93 | $7K | |
| 86901 | <1% | 1,181 | $6K | |
| 73660 | <1% | 85 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 75 | $6K |
| 83735 | <1% | 5,225 | $6K | |
| 84702 | <1% | 1,582 | $6K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 94 | $6K |
| 82077 | <1% | 1,389 | $6K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 866 | $5K |
| 80306 | <1% | 1,040 | $5K | |
| 70486 | <1% | 24 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,943 | $5K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 272 | $4K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 146 | $4K |
| 87040 | <1% | 1,897 | $4K | |
| 93976 | <1% | 126 | $4K | |
| 0637 | <1% | 37,212 | $4K | |
| 0710 | <1% | 2,085 | $4K | |
| 72040 | <1% | 68 | $4K | |
| 83605 | <1% | 2,293 | $4K | |
| 87631 | <1% | 205 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,780 | $4K |
| 73562 | <1% | 80 | $4K | |
| 59025 | Fetal non-stress test | <1% | 109 | $4K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 155 | $4K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,348 | $4K |
| 84703 | <1% | 3,678 | $4K | |
| 99070 | <1% | 262 | $3K | |
| 71250 | <1% | 41 | $3K | |
| 93971 | <1% | 127 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,088 | $3K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 38 | $3K |
| 81003 | <1% | 6,177 | $3K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 401 | $3K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,783 | $2K |
| 87088 | <1% | 2,125 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 235 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 235 | $2K |
| 85610 | <1% | 3,696 | $2K | |
| 96376 | <1% | 674 | $2K | |
| 85652 | <1% | 3,512 | $2K | |
| 0250 | <1% | 7,243 | $2K | |
| 85379 | <1% | 1,195 | $2K | |
| 84100 | <1% | 2,618 | $2K | |
| 80179 | <1% | 500 | $2K | |
| 82248 | <1% | 1,031 | $2K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 29 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 928 | $1K |
| 82962 | <1% | 3,547 | $1K | |
| 71101 | <1% | 12 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 988 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,230 | $1K |
| 85027 | <1% | 837 | $1K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,224 | $1K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 51 | $996.32 |
| Z7502 | <1% | 224 | $923.88 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 919 | $889.92 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 432 | $880.65 |
| 86140 | <1% | 685 | $830.44 | |
| 84132 | <1% | 392 | $756.92 | |
| 0272 | <1% | 151 | $711.71 | |
| 72141 | <1% | 24 | $630.00 | |
| 82570 | <1% | 116 | $576.40 | |
| 85378 | <1% | 366 | $485.88 | |
| 82310 | <1% | 139 | $358.38 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 295 | $331.67 |
| 82550 | <1% | 270 | $280.53 | |
| 84156 | <1% | 99 | $270.78 | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 157 | $234.73 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,110 | $228.28 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,106 | $200.31 |
| J1815 | Injection, insulin, per 5 units | <1% | 480 | $168.03 |
| 85730 | <1% | 109 | $105.05 | |
| 82803 | <1% | 39 | $85.29 | |
| 82040 | <1% | 116 | $78.73 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 170 | $78.59 |
| 87070 | <1% | 28 | $56.08 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 63 | $55.62 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 69 | $46.61 |
| 82728 | <1% | 12 | $38.88 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 196 | $32.21 |
| 87081 | <1% | 69 | $31.96 | |
| 87340 | <1% | 12 | $28.26 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 169 | $11.50 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 25 | $10.08 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 124 | $9.45 |
| C1769 | Guide wire | <1% | 82 | $9.00 |
| 87324 | <1% | 19 | $8.80 | |
| 87449 | <1% | 19 | $8.40 | |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 28 | $6.14 |
| 85008 | <1% | 25 | $2.60 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 37 | $0.08 |
| 76376 | 0% | 107 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 14 | $0.00 |
| 0370 | 0% | 1,841 | $0.00 | |
| 0258 | 0% | 243 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 46 | $0.00 |
| 80320 | 0% | 35 | $0.00 | |
| 88304 | 0% | 12 | $0.00 | |
| 80349 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMCKEOWN, COLLEEN (SENIOR VICE PRESIDENT, AREA MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Kaiser Foundation Hospitals | Antioch, CA | $15.10M |
| Kaiser Foundation Hospitals | Martinez, CA | $604K |
| Kaiser Foundation Hospitals | Martinez, CA | $438K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.